Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection. Matthews GV, Bhagani S, Van der Valk M, Rockstroh J, et al. J Hepatol 2021 May 20. pii: S0168-8278(21)00336.

Read + Share

Amedeo Smart

Independent Medical Education

Matthews GV, Bhagani S, Van der Valk M, Rockstroh J, et al. Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection. J Hepatol 2021 May 20. pii: S0168-8278(21)00336.
PMID: 34023350